CSTONE PHARMA-B (02616) issued 118 million new shares in accordance with the placing agreement.
Jichisheng Pharmaceutical-B (02616) announced that according to the placement agreement on April 14, 2026, it will issue and distribute 118 million new shares on April 22, 2026 under general authorization.
CSTONE PHARMA-B (02616) announced that according to the placement agreement on April 14, 2026, 1.18 billion new shares will be issued and distributed under general authorization on April 22, 2026.
Related Articles
JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.
SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.
XINXIN MINING (03833) will distribute a final dividend of 0.05 yuan per share.
JIANGSU EXPRESS (00177) plans to increase capital by 128 million yuan to Danjin Company.
SIMCERE PHARMA (02096): has voluntarily withdrawn the NDA for Ludechig Bai monoclonal antibody and is expected to resubmit the NDA later this month.
XINXIN MINING (03833) will distribute a final dividend of 0.05 yuan per share.
RECOMMEND
DeepSeek’s $10 Billion Valuation Financing Rumor And Four Layers Of Logical Judgment
21/04/2026
48 Hours Witness AI’s New Battlefield: Alibaba Joins, Tencent Open Sources, Manycore Tech Lists — Has The World Model Reached Its ChatGPT Moment?
21/04/2026
Public Fund Giants Reverse Course With Heavy Hong Kong IPO Cornerstone Allocations Exceeding HK$2.2 Billion Year‑To‑Date
21/04/2026
